Kubanda Cryotherapy

What Kubanda Cryotherapy does

Kubanda Cryotherapy is a privately held veterinary medical device company headquartered in Baltimore, Maryland, founded in 2018 to commercialize a minimally invasive, point-of-care cryoablation treatment for lumps, bumps, and cancers in companion animals. Its core product is a patented cryosystem comprising a cryoprobe and a gas-control module that destroys tumor cells through the formation of intracellular ice crystals, enabling treatment of benign and malignant masses without general anesthesia and with reduced healing times relative to surgery, chemotherapy, or radiation. The device is commercially available and is being used in veterinary clinics across the United States, and is the first and only Fear Free Preferred cryotherapy product in veterinary medicine, an industry credentialing distinction that supports brand differentiation and clinical adoption.

The company monetizes through direct hardware sales of its cryotherapy device and associated consumables to veterinary practices, using a quote-based, undisclosed pricing model with multi-year contracts and demo-driven sales led by a dedicated Sales Director. It complements device sales with an educational layer that includes a RACE-approved 1-hour continuing-education course for veterinarians (delivered via EdApp), multiple condition-specific eBooks (mammary tumors, lipomas, complex cases, surgical comparisons), webinars, and pet-parent handouts. A vet-locator service supports consumer-pull demand from pet owners seeking non-surgical tumor treatment alternatives for dogs and cats.

Kubanda was founded by Bailey Surtees (CEO) and Clarisse Hu (CTO), with Nicholas Durr as co-founder/advisor; the team is composed primarily of Johns Hopkins biomedical engineering alumni and includes clinical, R&D, and commercial roles. The company has raised approximately $835K cumulatively across state and non-dilutive sources (TEDCO, Maryland Innovation Initiative, FastForward U), Comcast RISE, and Boot64 Ventures, with its largest disclosed round of $500K from TEDCO in September 2025. Operations are US-only, the company holds an active patent on its cryoablation technology, and it operates without a parent company, public listing, or disclosed institutional lead investor beyond TEDCO and Boot64.

Name

Kubanda Cryotherapy

Legal name

Kubanda Cryotherapy

Website

https://kubandacryotherapy.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Kubanda Cryotherapy is a Baltimore-based veterinary medical device company that sells a patented intratumoral cryoablation system and consumables to veterinary practices for minimally invasive, point-of-care treatment of tumors in companion animals without general anesthesia.

Ownership category

akta.pro rank

Product category

Veterinary Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ)

akta.pro secondary industry

Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

Keywords

• Veterinary cryoablation
• Intratumoral cryotherapy
• Pet tumor treatment
• Veterinary medical devices
• Minimally invasive oncology

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Cryotherapy Device and Consumables: Sale of cryoablation devices and associated consumables for veterinary practices to perform intratumoral cryotherapy treatments on pets with tumors.

Pricing tiers

Distribution channels2 records

Marketing channels5 records

Core offering

Kubanda Cryotherapy designs, manufactures, and sells a custom cryoablation system (cryoprobe plus gas-control module) used by veterinarians to perform minimally invasive, point-of-care treatment of lumps, bumps, and cancers in companion animals. Procedures create freezing cycles that kill tumor cells through intracellular ice crystal formation and can be performed without general anesthesia. The company complements the device with educational content and continuing education for veterinary professionals.

Product overview

Kubanda Cryotherapy offers a cryoablation platform consisting of a cryoprobe and gas-control module for treating tumors in pets. The core product uses intracellular ice crystal formation to kill tumor cells at point-of-care. The company also provides a complementary portfolio of educational resources including a RACE-approved CE course, multiple eBooks (covering mammary tumors, lipomas, complex cases, and surgical comparisons), webinars, and patient handouts. All educational content supports the core device by training veterinarians on cryotherapy implementation and helping pet owners understand treatment options.

Differentiator

Problem solved

Functional benefit

Products and services

• Kubanda Cryotherapy System A veterinary cryoablation device consisting of a cryoprobe and gas-control module that kills tumor cells through intracellular ice crystal formation, enabling point-of-care treatment of benign and malignant tumors in pets without general anesthesia. The system fits into general veterinary workflows and is sold to veterinary clinics and specialty practices.
• RACE-Approved 1 Hour CE Course A continuing education course teaching veterinarians how to use cryotherapy to treat tumors in veterinary settings, delivered remotely through EdApp with RACEtrack and CE Broker reporting. It is a paid education offering that supports adoption of the core cryoablation device.

Quantifiable outcome

• Faster healing than surgery, chemo, or radiation
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• PetCure Oncology: Veterinary radiation oncology provider offering cancer treatment for companion animals. Directly comparable as both target the veterinary oncology treatment market, though PetCure uses radiation modalities versus Kubanda's cryoablation.
• IceCure Medical: Developer of cryoablation systems for tumor destruction using a similar minimally invasive, cold-based mechanism to Kubanda. Operates primarily in human oncology (breast, kidney, lung) but shares the same underlying cryoablation technology platform and clinical use case.

Broad incumbents

• Heska: Veterinary diagnostics and point-of-care medical device company (now part of Mars Petcare / Antech). Comparable in selling premium hardware instruments into veterinary practices, though Heska's portfolio is centered on diagnostics rather than treatment devices.
• BTL Group: Manufacturer of cryotherapy and aesthetic medical equipment, primarily for human physiotherapy and aesthetics. Uses similar cryogenic technology to Kubanda but addresses a much larger and different human end market at significantly greater scale.
• IDEXX Laboratories: Global leader in veterinary diagnostics, practice software, and water testing. Comparable in targeting veterinary clinics with premium hardware and consumables, but at vastly larger scale and focused on diagnostic rather than therapeutic devices.
• Sound Technologies: Veterinary imaging equipment provider (ultrasound, digital radiography, CT) now part of Antech / Mars Petcare. Comparable hardware GTM into veterinary practices, but addresses diagnostic imaging versus therapeutic oncology applications.
• Galil Medical (Boston Scientific): Pioneer in cryoablation technology for urology and oncology (acquired by Boston Scientific). Closest large-scale cryoablation incumbent, validating the underlying technology platform Kubanda uses but addressing the much larger human oncology market.
• Cryo Innovations: Manufacturer of whole-body and localized cryotherapy chambers for sports medicine, wellness, and rehabilitation. Uses similar cryogenic technology to Kubanda but addresses human consumer and clinical wellness rather than veterinary oncology.
• Midmark: Established manufacturer of veterinary and dental medical equipment, including exam tables, anesthesia machines, and monitoring devices. Comparable established veterinary equipment vendor selling into vet clinics at meaningful scale across the US.
• Covetrus: Major veterinary distribution and practice services company (now part of Patterson Companies). Operates in the veterinary channel infrastructure space adjacent to Kubanda's veterinary practice GTM, providing distribution reach into the same end customer base.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/kubandacryo

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kubanda Cryotherapy